Similar articles

• [Antipsychotic efficacy of neuroleptic neuropeptides in schizophrenia. Review of clinical data].

  Verhoeven VM. Verhoeven VM. Encephale. 1987 Nov-Dec;13(6):349-56. Encephale. 1987. PMID: 2453339 Review. French.
• Antipsychotic action of gamma-type endorphins: animal and human studies.

  van Ree JM, Verhoeven WM, Claas FH, de Wied D. van Ree JM, et al. Prog Brain Res. 1986;65:221-35. doi: 10.1016/S0079-6123(08)60653-6. Prog Brain Res. 1986. PMID: 2431435 Review. No abstract available.
• [Mental disorders and neuropeptides].

  Moroji T, Katsuura G. Moroji T, et al. Nihon Rinsho. 1990 May;48(5):1077-83. Nihon Rinsho. 1990. PMID: 1973953 Japanese. No abstract available.
• Gamma-type endorphins: neurolepticum-like and antipsychotic action.

  Van Ree JM, Verhoeven WM, De Wied D. Van Ree JM, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(5-6):561-7. doi: 10.1016/0278-5846(85)90017-x. Prog Neuropsychopharmacol Biol Psychiatry. 1985. PMID: 2418467
• [Endorphins of the gamma type in the treatment of schizophrenic psychoses].

  Verhoeven WM, Van Ree JM. Verhoeven WM, et al. Acta Psychiatr Belg. 1984 Mar-Apr;84(2):160-72. Acta Psychiatr Belg. 1984. PMID: 6204507 Clinical Trial. French.